Age as an independent factor for the development of neuropathy in diabetic patients
- PMID: 27042031
- PMCID: PMC4801151
- DOI: 10.2147/CIA.S97295
Age as an independent factor for the development of neuropathy in diabetic patients
Abstract
Population aging is unprecedented, without parallel in the history of humanity. As type 2 diabetes mellitus is predominantly more prevalent in aging populations, this creates a major public health burden. Older adults with diabetes have the highest rates of major lower-extremity amputation, myocardial infarction, visual impairment, and end-stage renal disease of any age group. The aims of our study were to assess whether age is an independent factor for the occurrence of diabetic neuropathy (DN), and to evaluate the relationship between the presence and the severity of DN and the diabetes duration and blood glucose level. In this study, we enrolled 198 patients, previously diagnosed with type 2 diabetes mellitus. For all patients, we measured hemoglobin A1c (HbA1c), lipid profile, and body mass index and we assessed the presence and severity of DN using the evaluation of clinical signs and symptoms. Patients had a median age of 62 years, with a median of diabetes duration of 7 years; 55.1% of the patients were men and the average HbA1c in the cohort was 8.2%. The prevalence of DN according to Michigan Neuropathy Screening Instrument was 28.8%, being significantly and positively correlated with higher age (65 vs 59 years; P=0.001) and HbA1c (8.6% vs 8.0%; P=0.027). No significant correlations were observed between the severity of DN and diabetes duration, body mass index (31.9 vs 29.9 kg/m(2)), or the number of centimeters exceeding the normal waist circumference (25.2 vs 17.3 cm; P=0.003). In conclusion, age influences the presence of DN, independent on other risk factors. This influence persists even after adjusting for other, very important risk factors, like blood glucose level or diabetes duration.
Keywords: body mass index; diabetic neuropathy; elderly patients; hemoglobin A1c; peripheral neuropathy; type 2 diabetes mellitus.
Figures
References
-
- International Diabetes Federation . Global Guideline for Managing Older People with Type 2 Diabetes. Belgium: International Diabetes Federation; 2013. pp. 6–7.
-
- Centers for Disease Control and Prevention . National Diabetes Fact Sheet: General Information and National Estimates on Diabetes in the United States. Atlanta, GA: US Department of Health and Human Services; 2011.
-
- Brown AF, Mangione CM, Saliba D, Sarkisian CA, California Health-care Foundation/American Geriatrics Society Panel on Improving Care for Elders with Diabetes Guidelines for improving the care of the older person with diabetes mellitus. J Am Geriatr Soc. 2003;51(Suppl Guidelines):S265–S280. - PubMed
-
- Vinik AI, Mitchell BD, Leichter SB, Wagner AL, O’Brian JT, Georges LP. Epidemiology of the complications of diabetes. In: Leslie RDG, Robbins DC, editors. Diabetes: Clinical Science in Practice. Cambridge, UK: Cambridge University Press; 1995. pp. 221–287.
-
- Knuiman M, Welborn T, McCann V, Stanton K, Constable I. Prevalence of diabetic complications in relation to risk factors. Diabetes. 1986;35:1332–1339. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials